Whether lithium inhibits glycogen synthase kinase (GSK)-3β activity in vivo in humans is still an open question

Research output: Contribution to journalComment/debate

1 Scopus citations
Original languageEnglish
Pages (from-to)464-467
Number of pages4
JournalBipolar Disorders
Volume18
Issue number5
DOIs
StatePublished - 1 Aug 2016

Keywords

  • bipolar disorder
  • glycogen synthase kinase (GSK)-3β
  • lithium
  • therapeutic mechanism

Cite this